Navigation Links
Data for Investigational Tiotropium Show Improved Lung Function and Sustained Bronchodilation in Patients with Moderate Asthma Severity
Date:9/10/2013

RIDGEFIELD, Conn., Sept. 10, 2013 /PRNewswire/ -- Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 mcg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.

These new data from the MezzoTinA-asthma® Phase 3 studies also showed the addition of once-daily tiotropium delivered via the Respimat® inhaler provided a statistically significant improvement in asthma control responder rate, as measured by the Asthma Control Questionnaire (ACQ).

"These results give us insight into the potential efficacy of tiotropium in the subset of asthma patients who remain symptomatic despite using medium-dose ICS and show that the addition of tiotropium may provide improvements in asthma control and lung function that could be clinically meaningful," said lead study author Professor Huib A.M. Kerstjens of the University Medical Centre, Groningen, The Netherlands. "A significant proportion of asthma patients trea
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Takedas New Investigational Drug Vedolizumab is Granted Priority Review Status by U.S. Food and Drug Administration for Ulcerative Colitis
2. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
3. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
4. New Data for Abbotts Investigational High Sensitive Troponin Test Shows It May Help Doctors Predict Heart Attack Risk
5. Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University
6. Signum Dermalogix Investigational New Drug (IND) Application Cleared by FDA: SIG990 a Potential Treatment for Rosacea
7. Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
8. Phase III study finds investigational agent empagliflozin significantly reduced blood glucose in adults with type 2 diabetes and impaired kidney function
9. Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
10. Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
11. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  Delcath Systems, Inc. ... medical device company focused on oncology with an ... liver cancers, announces the reporting of data from ... Hydrochloride for Injection with the Delcath Hepatic Delivery ... presentation at the Society of Surgical Oncology (SSO) ...
(Date:3/26/2015)... 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" ... focus on Omega-3 therapies for cardiovascular disease and overall ... 763,752 common shares of the Corporation (the "Common Shares"). ... period of December 5 th , 2014 to March ... that is due on or before April 1, 2015. ...
(Date:3/26/2015)... 2015 Cardiologists at Beaumont Hospital, ... commercial implant of a device recently approved by the ... fibrillation. The Watchman Left Atrial Appendage Closure implant is ... to reduce the risk of stroke. Atrial ... more than 5 million Americans. Twenty percent of all ...
Breaking Medicine Technology:Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3
... , MOUNTAIN VIEW, Calif., Dec. 14 Alexza Pharmaceuticals, ... submitted its New Drug Application (NDA) for Staccato® loxapine (AZ-004) ... is an inhalation product candidate being developed for the rapid ... The IND for Staccato loxapine was filed ...
... , DENVER, Dec. 14 Corgenix Medical Corporation (OTC ... diagnostic test kits, and BG Medicine, Inc. (BGM), a ... agreement whereby Corgenix will manufacture BGM Galectin-3 diagnostic products ... BG Medicine. BG Medicine is seeking regulatory clearance in ...
Cached Medicine Technology:Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2
(Date:3/28/2015)... March 28, 2015 ARDX will sponsor the ... 12pm -3pm at the Chesapeake Conference Center in Chesapeake, Virginia. ... an empowering event for women in the Hampton Roads region. ... Stories of Women’s Lives. Women grow stronger through sharing ... other. This year the WWC™ theme is T-talk where ...
(Date:3/27/2015)... March 27, 2015 Wellness for Cancer–the ... business criteria for the spa and wellness industry–has certified ... who have experienced or are living with cancer. ... Wellness 365® Network, will be identified with a special ... a provider of safe, therapeutic services for cancer patients. ...
(Date:3/27/2015)... Bleeding is one of the ... intervention (PCI), resulting in increased mortality, morbidity, and ... in which the highest-risk PCI patients with the ... often with bleeding avoidance strategies than lower-risk patients. ... Heart Institute asked the question whether prospectively determining ...
(Date:3/27/2015)... The report “CountryFocus Healthcare, Regulatory and ... of information on and analysis of the healthcare, ... elderly population and its associated disease burden are ... the elderly accounted for 27.1% of the total ... Rate (CAGR) of 1.2% to 29.5% in 2020. ...
(Date:3/27/2015)... Michigan (PRWEB) March 27, 2015 ... LiveToBeSober.org, along with former Detroit Lions wide receiver ... luncheon and educational presentation on substance abuse, treatment ... Among those who attended were pastors, ministers and ... leaders and other distinguished guests. , “Our ‘Fighting ...
Breaking Medicine News(10 mins):Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 3Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 2Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 3Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 4Health News:LiveToBeSober.org Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2
... , , WOONSOCKET, ... keep Americans healthy this flu season, CVS Caremark today announced its ... The program will include on-site flu clinics at One-Stop Career ... CVS/pharmacy or MinuteClinic. One-Stop Career Centers offer tools and training ...
... , , , N. ... Restylane(R), Perlane(R) and Juvederm(R) are popular for their ability to ... the more sensitive aesthetic patient, the possibility of experiencing injection ... improvement that could be theirs. , , ...
... , , , ... medical technology systems integrator transforming critical care, announced that former Veterans ... Board of Advisors. , , Secretary Peake retired ... and commander in several medical posts culminating in his appointment as ...
... ... in Wyoming, a subsidiary of The Eye Institute of Utah – a prominent ... practice - is the recipient of a national award recognizing the quality of ... in Utah, The Eye Institute’s Rock Springs, Wyoming location has been named by ...
... ... lifelong resident of San Antonio, is on the grow. "Bold moves are made in times ... ... Thom Robey, lifelong resident of San Antonio, is on the grow. "Bold moves are made ...
... have sex with men (MSM) in the township of Soweto in ... infected with HIV. The study,s authors were ... have sex with men in the Soweto Township, an area on ... The researchers found that Soweto MSM identified themselves as ...
Cached Medicine News:Health News:CVS Caremark to Provide $3 Million in Free Flu Shots to the Unemployed 2Health News:CVS Caremark to Provide $3 Million in Free Flu Shots to the Unemployed 3Health News:Painless, Bruise-free Dermal Filler Injections 2Health News:Former Veterans Affairs Secretary Joins Integrated Medical Systems' Advisory Board 2Health News:Former Veterans Affairs Secretary Joins Integrated Medical Systems' Advisory Board 3Health News:The Eye Institute Receives 2009 Best of Rock Springs Award from U.S. Commerce Association 2Health News:The Eye Institute Receives 2009 Best of Rock Springs Award from U.S. Commerce Association 3Health News:REES Announces New San Antonio Office 2Health News:High HIV infection rate among Soweto Township gays 2
This design features a solid red iris....
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Silicone tip cannula angled at 7 mm, sterile, disposable (bx/10)....
Medicine Products: